Status:
UNKNOWN
Efficacy of the Apollo System for Children With ADHD
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
The Board of Medicine
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
To determine the extent to which the Apollo System is effective in reducing symptomatology associated with ADHD.
Detailed Description
The objective of this project is to understand the potential therapeutic benefits of the Apollo System for children with ADHD. Using vibrational therapy, the Apollo System has been previously demonstr...
Eligibility Criteria
Inclusion
- All individuals that agreed to participate will be selected on a first come, first serve basis. No individual will be turned down due to sex, race, or ethnicity. The following inclusion criteria exist for all participants:
- Participants must be 8 years of age or older and under the age of 18.
- Participants must have diagnosed or suspected Attention Deficit Hyperactivity Disorder (ADHD).
- Participants must have one of the following: 1) on the same treatment plan for over a year with minimal symptom relieve or alleviation, 2) tried two or more treatment approaches but is unable to meet treatment goals, 3) taking medication but still has symptoms, or 4) unwanted or uncontrollable side effects related to the medication.
- Participants must have normal or corrected-to-normal vision in order to complete the cognitive task.
Exclusion
- The following exclusion criteria exist for all participants:
- Lack of consent.
- Participants cannot have started a new treatment within the last 30 days.
- Participants cannot have a history of hydrocephalus, Autism Spectrum Disorder, Schizophrenia, Conduct disorder, Oppositional Defiant Disorder, active substance abuse, or be on a beta blocker.
- Participants cannot have previously used the Apollo System.
Key Trial Info
Start Date :
March 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05308706
Start Date
March 18 2022
End Date
August 15 2024
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Kinesiology
East Lansing, Michigan, United States, 48824